Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
ARS Pharmaceuticals
SPRY
$601M
| $1.81M | ﹤0.01% |
329,550
+5,147
| +2% | +$22.6K |
|
|
ML
2652
DELISTED
MoneyLion Inc.
ML
| $1.8M | ﹤0.01% |
28,777
-1,699
| -6% | -$57.1K |
|
2653
Omega Flex
OFLX
$304M
| $1.8M | ﹤0.01% |
25,528
+266
| +1% | +$19.9K |
|
2654
Grindr
GRND
$2.76B
| $1.79M | ﹤0.01% |
204,213
-2,283
| -1% | -$15.4K |
|
2655
Atea Pharmaceuticals
AVIR
$405M
| $1.78M | ﹤0.01% |
584,326
+2,093
| +0.4% | +$6.34K |
|
|
DQ
2656
Daqo New Energy
DQ
$988M
| $1.76M | ﹤0.01% |
66,262
-1,159
| -2% | -$29.5K |
|
2657
Regional Management Corp
RM
$297M
| $1.75M | ﹤0.01% |
69,601
| – | – |
|
2658
AlTi Global
ALTI
$457M
| $1.75M | ﹤0.01% |
199,220
+16,772
| +9% | +$126K |
|
2659
SIGA Technologies
SIGA
$206M
| $1.74M | ﹤0.01% |
310,849
-9,738
| -3% | -$52.2K |
|
|
OLPX
2660
DELISTED
Olaplex Holdings
OLPX
| $1.73M | ﹤0.01% |
681,627
+92,344
| +16% | +$182K |
|
2661
National Grid
NGG
$81.1B
| $1.72M | ﹤0.01% |
26,905
+7,651
| +40% | +$457K |
|
|
PSTX
2662
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1.71M | ﹤0.01% |
509,763
+6,687
| +1% | +$17.2K |
|
2663
Senseonics Holdings Inc
SENS
$419M
| $1.71M | ﹤0.01% |
149,963
+28,569
| +24% | +$326K |
|
2664
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.42B
| $1.71M | ﹤0.01% |
13,663
-726
| -5% | -$81.4K |
|
|
NLOP
2665
Net Lease Office Properties
NLOP
$171M
| $1.71M | ﹤0.01% |
+92,396
| New | +$1.54M |
|
2666
Nuvation Bio
NUVB
$2.25B
| $1.7M | ﹤0.01% |
1,126,663
+84,510
| +8% | +$109K |
|
2667
Heron Therapeutics
HRTX
$64.7M
| $1.7M | ﹤0.01% |
997,201
+14,192
| +1% | +$15.6K |
|
|
YMAB
2668
DELISTED
Y-mAbs Therapeutics
YMAB
| $1.69M | ﹤0.01% |
247,506
-1,938
| -0.8% | -$11.2K |
|
2669
RE/MAX Holdings
RMAX
$263M
| $1.68M | ﹤0.01% |
126,167
-10,312
| -8% | -$113K |
|
2670
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
| $1.68M | ﹤0.01% |
58,852
-1,630
| -3% | -$45.2K |
|
2671
KRONOS Worldwide
KRO
$905M
| $1.67M | ﹤0.01% |
168,374
-9,773
| -5% | -$79.4K |
|
2672
Entravision Communication
EVC
$832M
| $1.67M | ﹤0.01% |
400,972
-6,191
| -2% | -$24.5K |
|
2673
Ceco Environmental
CECO
$4.44B
| $1.66M | ﹤0.01% |
81,933
| – | – |
|
2674
Clover Health Investments
CLOV
$2.41B
| $1.64M | ﹤0.01% |
1,718,730
-109,793
| -6% | -$108K |
|
|
SMLR
2675
DELISTED
Semler Scientific
SMLR
| $1.63M | ﹤0.01% |
36,881
-1,971
| -5% | -$70.8K |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.